These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6165131)

  • 1. Effect of 17-alpha-hydroxyprogesterone 17-n-caproate on urine flow.
    Brooks ME; Braf ZF
    Urology; 1981 May; 17(5):488-91. PubMed ID: 6165131
    [No Abstract]   [Full Text] [Related]  

  • 2. Failure of hydroxyprogesterone caproate to maintain pregnancy in ovariectomised mares.
    McKinnon AO; Tarrida del Marmol Figueroa S; Nobelius AM; Hyland JH; Vasey JR
    Equine Vet J; 1993 Mar; 25(2):158-60. PubMed ID: 8467776
    [No Abstract]   [Full Text] [Related]  

  • 3. Adjuvant hydroxyprogesterone caproate in stage I endometrial carcinoma: changes in numbers and reactivities of some blood lymphocyte subpopulations.
    Onsrud M
    Gynecol Oncol; 1982 Dec; 14(3):355-64. PubMed ID: 6983994
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of progestational agents for postmenopausal hot flushes.
    Roopnarinesingh S
    Int J Gynaecol Obstet; 1982 Apr; 20(2):133-5. PubMed ID: 6125433
    [No Abstract]   [Full Text] [Related]  

  • 5. Adjuvant hormone therapy of primary endometrial carcinoma with oxyprogesterone caproate.
    Bokhman JV; Chepick OF; Volkova AT; Vishnevsky AS
    Gynecol Oncol; 1981 Jun; 11(3):371-8. PubMed ID: 6788657
    [No Abstract]   [Full Text] [Related]  

  • 6. [Phonophoresis of hydroxyprogesterone capronate in the treatment of the patients with adenoma of the prostate complicated by dysuria].
    Karpukhin VT; Sapozhnikov VV
    Vopr Kurortol Fizioter Lech Fiz Kult; 1981; (6):46-9. PubMed ID: 6175097
    [No Abstract]   [Full Text] [Related]  

  • 7. 17-alpha-Hydroxyprogesterone caproate and natural progesterone in assisted reproduction: a comparative study.
    Abate A; Brigandì A; Costabile L; Abate FG; Balzano E; Perino M
    Clin Exp Obstet Gynecol; 1997; 24(4):190-2. PubMed ID: 9478315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of hypertrophy of the prostate with gestagens].
    Vahlensieck W; Gödde S
    Munch Med Wochenschr; 1968 Jun; 110(26):1573-7. PubMed ID: 4182927
    [No Abstract]   [Full Text] [Related]  

  • 9. Predictors of response to 17-alpha hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth.
    Manuck TA; Esplin MS; Biggio J; Bukowski R; Parry S; Zhang H; Huang H; Varner MW; Andrews W; Saade G; Sadovsky Y; Reddy UM; Ilekis J;
    Am J Obstet Gynecol; 2016 Mar; 214(3):376.e1-8. PubMed ID: 26692181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of hydroxyprogesterone caproate in the treatment of benign prostatic hyperplasia.
    Jacobs D; Harper JM; Politano VA
    South Med J; 1967 Nov; 60(11):1174-6. PubMed ID: 4168673
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of hydroxyprogesterone caproate on experimental benign prostatic obstruction in the mouse.
    Caine M; Superstine E
    Isr J Med Sci; 1973; 9(11):1559-64. PubMed ID: 4130461
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prolonged medical therapy using mepartricin in prostatic hypertrophy. Results in 81 patients].
    Serretta V; Pavone C; Di Trapani D; Romano C; Costa G; Caramia G
    Minerva Urol Nefrol; 1988; 40(2 Suppl):55-8. PubMed ID: 2460954
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of benign prostatic hypertrophy using mepartricin at high dosage].
    Giurioli A; Rosi P; Parziani S; Cesaroni M; Ghamari MR
    Minerva Urol Nefrol; 1988; 40(2 Suppl):38-9. PubMed ID: 2460947
    [No Abstract]   [Full Text] [Related]  

  • 14. Endocrine effects of 17 alpha-hydroxyprogesterone caproate during early pregnancy: a double-blind clinical trial.
    Reijnders FJ; Thomas CM; Doesburg WH; Rolland R; Eskes TK
    Br J Obstet Gynaecol; 1988 May; 95(5):462-8. PubMed ID: 3135831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical evaluation of the use of mepartricin in the therapy of prostatic hypertrophy. Double-blind study].
    Cortecchia V; Scarano P; D'Amato G; Soli M; Rusconi R; Buli P
    Minerva Urol Nefrol; 1988; 40(2 Suppl):44-6. PubMed ID: 2460949
    [No Abstract]   [Full Text] [Related]  

  • 16. Suppression of threatened premature labor by administration of cortisol and 17 alpha-hydroxyprogesterone caproate: a comparison with ritodrine.
    Kauppila A; Hartikainen-Sorri AL; Jänne O; Tuimala R; Järvinen PA
    Am J Obstet Gynecol; 1980 Oct; 138(4):404-8. PubMed ID: 7424996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can primary endometrial carcinoma stage I be cured without surgery and radiation therapy?
    Bokhman JV; Chepick OF; Volkova AT; Vishnevsky AS
    Gynecol Oncol; 1985 Feb; 20(2):139-55. PubMed ID: 3972284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commentary on tolterodine for men with benign prostatic hyperplasia and lower urinary tract symptoms.
    O'Leary MP
    J Urol; 2008 May; 179(5 Suppl):S86. PubMed ID: 18405764
    [No Abstract]   [Full Text] [Related]  

  • 19. [Randomized double-blind study using mepartricin and a placebo in the therapy of benign prostatic hypertrophy].
    Miano L; Manieri C; Paradiso Galatioto G
    Minerva Urol Nefrol; 1988; 40(2 Suppl):50-2. PubMed ID: 2460952
    [No Abstract]   [Full Text] [Related]  

  • 20. TREATMENT OF BENIGN PROSTATIC HYPERTROPHY WITH HYDROXYPROGESTERONE CAPROATE: EFFECT ON CLINICAL SYMPTOMS, MORPHOLOGY, AND ENDOCRINE FUNCTION.
    GELLER J; BORA R; ROBERTS T; NEWMAN H; LIN A; SILVA R
    JAMA; 1965 Jul; 193():121-8. PubMed ID: 14304354
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.